Terkko Navigator / Lancet Infectious Diseases

Unmet need for COVID-19 therapies in community settings

Risk factors for the spread of vaccine-derived type 2 polioviruses after global withdrawal of trivalent oral poliovirus vaccine and the effects of outbreak responses with monovalent vaccine: a retrospective analysis of surveillance data for 51 countr

Polio eradication: what kind of world do we want?

Xpert MTB/XDR for rapid detection of drug-resistant tuberculosis beyond rifampicin

Community-acquired pneumonia: is less more?

Detection of isoniazid, fluoroquinolone, ethionamide, amikacin, kanamycin, and capreomycin resistance by the Xpert MTB/XDR assay: a cross-sectional multicentre diagnostic accuracy study

Implications of suboptimal COVID-19 vaccination coverage in Florida and Texas

Narrow-spectrum antibiotics for community-acquired pneumonia in Dutch adults (CAP-PACT): a cross-sectional, stepped-wedge, cluster-randomised, non-inferiority, antimicrobial stewardship intervention trial

Migration and outbreaks of vaccine-preventable disease in Europe: a systematic review

Voices from the abyss

The value of open-source clinical science in pandemic response: lessons from ISARIC

Acute flaccid paralysis in a young woman

Disseminated Talaromyces marneffei infection mimicking intestinal tuberculosis

Addendum needed on COVID-19 travel study – Authors' reply

Addendum needed on COVID-19 travel study

Correction to Lancet Infect Dis 2021; 21: 929–38

Safety and immunogenicity of an inactivated COVID-19 vaccine, BBIBP-CorV, in people younger than 18 years: a randomised, double-blind, controlled, phase 1/2 trial

Remdesivir, on the road to DisCoVeRy

Prevention of host-to-host transmission by SARS-CoV-2 vaccines

Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial

Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial

India's COVID-19 vaccination drive: key challenges and resolutions

Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trial

Ebola vaccines for mass immunisation in affected regions

Dynamic IgG seropositivity after rollout of CoronaVac and BNT162b2 COVID-19 vaccines in Chile: a sentinel surveillance study

Protection against COVID-19: beyond antibodies

The importance of understanding the infectious microenvironment

Correction to Lancet Infect Dis 2021; published online Aug 19. https://doi.org/10.1016/S1473-3099(21)00203-6

100 years of Mycobacterium bovis bacille Calmette-Guérin

Hospitalisation among vaccine breakthrough COVID-19 infections

Comparison of three tests for latent tuberculosis infection in high-risk people in the USA: an observational cohort study

Correction to Lancet Infect Dis 2020; published online Aug 5. https://doi.org/10.1016/S1473-3099(21)00191-2

Hospitalisation associated with SARS-CoV-2 delta variant in Denmark

Herpetic oesophagitis in an immunocompetent infant with gastroesophageal reflux

Importance of non-pharmaceutical interventions in lowering the viral inoculum to reduce susceptibility to infection by SARS-CoV-2 and potentially disease severity

Scaling up COVID-19 rapid antigen tests: promises and challenges

Genomic-informed pathogen surveillance in Africa: opportunities and challenges

Barriers and enablers to implementing tuberculosis control strategies in EU and European Economic Area countries: a systematic review

Cryptococcal meningoencephalitis: time for action

Treponema pallidum detection in lesion and non-lesion sites in men who have sex with men with early syphilis: a prospective, cross-sectional study

Efficacy and safety of suvratoxumab for prevention of Staphylococcus aureus ventilator-associated pneumonia (SAATELLITE): a multicentre, randomised, double-blind, placebo-controlled, parallel-group, phase 2 pilot trial

Treatment of disseminated nocardiosis: a host–pathogen approach with adjuvant interferon gamma

Vaccination of human participants with attenuated Necator americanus hookworm larvae and human challenge in Australia: a dose-finding study and randomised, placebo-controlled, phase 1 trial

Global guideline for the diagnosis and management of rare yeast infections: an initiative of the ECMM in cooperation with ISHAM and ASM

An urgent need: vaccines for neglected tropical diseases

Persistent SARS-CoV-2 infection: the urgent need for access to treatment and trials

Bell's palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study

The association between COVID-19 vaccination and Bell's palsy

Vaccinating children: fairness and childism

Rapid genome sequencing in hospitals to identify potential vaccine-escape SARS-CoV-2 variants